Frequent aneuploidy in primary human T cells after CRISPR–Cas9 cleavage
Alessio D. Nahmad(Rabin Medical Center), Adi Barzel(Tel Aviv University), Tamar Tenne(Meir Medical Center), Hila Kobo(Tel Aviv University), Uri Ben‐David(Tel Aviv University), Ella Goldschmidt(Tel Aviv University), Rami Khosravi(Tel Aviv University), Eli Reuveni(Tel Aviv University), Asaf Madi(Tel Aviv University), Eyal Reinstein(Technion – Israel Institute of Technology), Meytal Liberman(Meir Medical Center), Miriam Horovitz‐Fried(Tel Aviv University)
Cited by 207
Related Papers
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
The 2017 international classification of the Ehlers–Danlos syndromes
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|1.9k
The tumorigenicity of human embryonic and induced pluripotent stem cells
|Nature reviews. Cancer|2011|886
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
|Nature Cancer|2020|880